1 (626) 351-3700

Portfolio

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust immune response and a decrease of tumor biomarkers in […]

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial Read More »

Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics

BURLINGAME, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) — Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license agreement with Five Prime Therapeutics, Inc. (NASDAQ:FPRX). The non-exclusive license grants Five Prime rights to use the AlivaMab Mouse for antibody drug discovery and development. “Ablexis is

Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics Read More »

Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma

AlivaMab Mouse Emerging as Top Pharmas’ Next-Generation Antibody Drug Discovery Platform of Choice BURLINGAME, Calif.–(BUSINESS WIRE)– 2, 2016 – Ablexis, LLC announced today the expansion of the roster of licensees of its AlivaMab Mouse technology to include an additional top 15 pharmaceutical company. The AlivaMab Mouse is a unique, next-generation transgenic mouse platform for human

Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma Read More »

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood | Business Wire ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted expanded Indications for Use of the company’s patented PleuraFlow® Active Clearance Technology® System. The PleuraFlow System is

FDA Expands Label Indication for PleuraFlow to Reduce Retained Blood Read More »

ClearFlow’s PleuraFlow System Exhibited at Association of Physician Assistants in Cardiovascular Surgery Meeting

Anaheim, CA – March 2, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the 34th annual Association of Physician Assistants in Cardiovascular Surgery (APACVS) meeting in Las Vegas. PleuraFlow will also be displayed at the Maquet Medical Systems USA booth through March 4th.

ClearFlow’s PleuraFlow System Exhibited at Association of Physician Assistants in Cardiovascular Surgery Meeting Read More »

OrthAlign, Inc. Receives CE Mark Approval for ORTHALIGN PLUS®, the most complete palm-sized positioning device for use in Total Hip Arthroplasty Surgery: Acetabular Cup Placement, Leg Length, and Joint Offset

Aliso Viejo, CA – February 3, 2015 – OrthAlign, Inc., a privately held medical device and technology company, received CE Mark Approval to market its OrthAlign Plus® system, a palm-sized, single-use positioning device for Total Hip (acetabular cup placement, leg length, and joint offset) and Total Knee (tibial and femoral) Arthroplasty surgeries, in Europe and

OrthAlign, Inc. Receives CE Mark Approval for ORTHALIGN PLUS®, the most complete palm-sized positioning device for use in Total Hip Arthroplasty Surgery: Acetabular Cup Placement, Leg Length, and Joint Offset Read More »

Education.com Names Former Adobe and Yahoo Executive Culligan to COO Post

New COO prepares early education leader for next phase of growth REDWOOD CITY, Calif., Jan. 29, 2015 — Surpassing 70 million visitors in 2014, Education.com has named Burke Culligan its Chief Operating Officer (COO). Culligan previously served in senior product management roles for Adobe Systems Digital Documents group and Yahoo’s Global HomePage group.  As Education.com’s COO,

Education.com Names Former Adobe and Yahoo Executive Culligan to COO Post Read More »

Maquet Medical Systems USA Announces Exclusive US Distribution Agreement with ClearFlow for PleuraFlow® Active Clearance Technology® System

WAYNE, N.J., Jan. 23, 2015 /PRNewswire/ — Maquet Medical Systems USA announced today an exclusive US distribution agreement with ClearFlow, Inc. for its innovative PleuraFlow® Active Clearance Technology® (ACT™) System. The PleuraFlow System enables caregivers to actively keep chest drainage tubes clear of clot in the early hours after heart surgery. Maquet’s sales representatives in

Maquet Medical Systems USA Announces Exclusive US Distribution Agreement with ClearFlow for PleuraFlow® Active Clearance Technology® System Read More »

Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc.

Novel, Fully Validated Transgenic Mouse Platform for the Discovery of Antibody Therapeutics Delivered to Pfizer and Other Licensees Earlier in 2014 San Francisco – December 4, 2014 – Ablexis, LLC today announced the completion and delivery to its licensees of its AlivaMab Mouse technology, an innovative and unique platform for discovery of the next generation of breakthrough

Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc. Read More »

Scroll to Top